Zobrazeno 1 - 10
of 26
pro vyhledávání: '"D. Bourgouin-Karaouni"'
Publikováno v:
European Respiratory Journal. 1:41-50
Almitrine bismesylate, a chemoreceptor agonist, improves blood gases in chronic obstructive lung disease (COLD). Some authors have observed an increase in pulmonary artery pressure (Ppa) after single doses of almitrine bismesylate (A). This led to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1694dc87eed707997d5657c34883caa9
https://doi.org/10.1183/09031936.93.01010041
https://doi.org/10.1183/09031936.93.01010041
Autor:
D. Bourgouin-Karaouni, Ch. Préfaut
Publikováno v:
La Revue de Médecine Interne. 6:3-7
Resume L'action favorable sur les gaz du sang du bismesilate d'almitrine — un agoniste des chemorecepteurs — est attribuee par l'ensemble des auteurs a une redistribution du rapport ventilation/perfusion. Le mecanisme de ce phenomene n'est pas cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4ea32fe909fd36b2a7cf28945cffe9d
https://doi.org/10.1016/s0248-8663(85)80138-7
https://doi.org/10.1016/s0248-8663(85)80138-7
Autor:
D. Bourgouin-Karaouni, C. Préfaut
Publikováno v:
La Revue de Médecine Interne. 6:15-20
Resume Le bismesilate d'almitrine est un agoniste des chemorecepteurs peripheriques dont le mode d'action procede d'une homogeneisation du rapport ventilation/perfusion. Son efficacite depend du bien-fonde de l'indication: c'est une therapeutique res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::212b6ae2027591295e8253ceb7f5ec6a
https://doi.org/10.1016/s0248-8663(85)80141-7
https://doi.org/10.1016/s0248-8663(85)80141-7
Autor:
C, Préfaut, D, Bourgouin-Karaouni
Publikováno v:
La Revue de medecine interne.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::229f6d59ce090dd7c09b49afb96a7a71
https://pubmed.ncbi.nlm.nih.gov/3914681
https://pubmed.ncbi.nlm.nih.gov/3914681
Publikováno v:
Revue des maladies respiratoires. 1(4)
Six subjects suffering from chronic airflow obstruction and respiratory failure were treated with oral almitrine bismesylate (3 mg/kg/day). Studies were made before and after 2 and 4 months treatment on: total ventilation, arterial blood gases, pulmo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f57309aa0de59e389f56b151a447e0ba
https://pubmed.ncbi.nlm.nih.gov/6505362
https://pubmed.ncbi.nlm.nih.gov/6505362
Publikováno v:
The American review of respiratory disease. 134(6)
Extracellular adenosine triphosphate (ATP) has potent systemic vasodilator and endothelial-dependent relaxant effects on precontracted vessels. Pulmonary uptake and metabolism of ATP have been described, but experimental effects on pulmonary vessels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b60cf4e085703c6f2184bb1a678e86d5
https://pubmed.ncbi.nlm.nih.gov/3789516
https://pubmed.ncbi.nlm.nih.gov/3789516
Autor:
D, Bourgouin-Karaouni, C, Préfaut
Publikováno v:
La Revue de medecine interne.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7af592288cc08d422293843c9e2ee5e
https://pubmed.ncbi.nlm.nih.gov/3938853
https://pubmed.ncbi.nlm.nih.gov/3938853
Publikováno v:
Bulletin europeen de physiopathologie respiratoire. 19(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f17e80402c8b5bd24de447f26bc18ca5
https://pubmed.ncbi.nlm.nih.gov/6850149
https://pubmed.ncbi.nlm.nih.gov/6850149
Publikováno v:
European journal of respiratory diseases. Supplement. 146
Almitrine bismesylate is a chemoreceptor agonist which has been shown to improve arterial blood gas values in chronic obstructive pulmonary disease (COPD) patients, possibly through better ventilation/perfusion matching. On these basis, long term stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5111e29588149aae397a4b49a649fff
https://pubmed.ncbi.nlm.nih.gov/3096767
https://pubmed.ncbi.nlm.nih.gov/3096767
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.